Wednesday 18 June 2014

Phase 3 data demonstrate comparability of Epirus’ BOW015 to Remicade for rheumatoid arthritis: « New Drug Approvals

Phase 3 data demonstrate comparability of Epirus’ BOW015 to Remicade for rheumatoid arthritis: « New Drug Approvals:



'via Blog this'

No comments:

Post a Comment